# Virtue

> Virtue is a VC fund in Austin backing Health Care and Artificial Intelligence. See 26 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Austin, United States
- Total investments: 26
- Last investment: Jul 2026
- Lead investor: 35%
- Fund size: $31M
- Last fund: Dec 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/virtuevc/
- X (Twitter): https://twitter.com/virtue_vc
- Website: https://www.virtuevc.com/

Virtue is a venture capital firm that invests in pre-seed & seed healthcare founders.

## Contacts

5 contacts available for Virtue. Shizune tracks 4 team members at Virtue. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/virtuevc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 11 | 42% |
| Artificial Intelligence | 5 | 19% |
| Medical | 3 | 12% |
| Information Technology | 3 | 12% |
| Software | 2 | 8% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 13 | 50% |
| Series A | 8 | 31% |
| Pre-Seed | 2 | 8% |
| Series B | 1 | 4% |
| Funding Round | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Sean Dolan | Founder | 0 | https://shizune.co/investors/profile/sean-doolan-d002 |
| Emre Karatas | Partner | 0 | https://shizune.co/investors/profile/emre-karatas |
| Michael Ragheb | Limited Partner | 0 | https://shizune.co/investors/profile/michael-ragheb |
| Sean Dolan | Founder | 6 | https://shizune.co/investors/profile/sean-dolan-e249 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kanurra | Kanurra is a pass-through pharmacy benefit manager for self-funded and level-funded companies that focuses on removing PBM spread, rebate retention, and other hidden costs. | $6.4M | Seed | Jul 27, 2026 |  |
| Solstice Health | Solstice Health is an AI life sciences marketing platform that offers a clinical data retrieval platform for oncology practice. | $21M | Series A | May 28, 2026 |  |
| Translucent AI | Translucent AI develops an AI-powered financial platform tailored for healthcare operators. The system automates financial reporting, consolidates data from various service lines, and provides real-time insights to support decision-making. It integrates with existing financial systems to streamline operations and reduce reliance on manualprocesses. The platform is designed to handle complex healthcare financial workflows and is built with security and compliance in mind. Translucent AI aims to enhance financial transparency and operational efficiency for healthcare organizations. | $27M | Series A | Mar 11, 2026 |  |
| Gyde | Gyde is an insurance technology company that operates an AI-native brokerage platform designed to support insurance professionals and agencies with digital tools and services. It provides an intelligent assistant that automates client outreach, scheduling, reminders, and routine communications to help brokers manage insurance, health, and wealthneeds. The company also offers a broker operating system that organizes meetings, captures context, and suggests cross-sell opportunities to streamline workflow. Gyde partners with agency owners through a model that integrates technology and operational support to augment traditional brokerage functions. Its platform is built to assist licensed agents in client service and administrative tasks while facilitating comprehensive advisory interactions. |  | Seed | Jan 28, 2026 |  |
| Gyde | Gyde is an insurance technology company that operates an AI-native brokerage platform designed to support insurance professionals and agencies with digital tools and services. It provides an intelligent assistant that automates client outreach, scheduling, reminders, and routine communications to help brokers manage insurance, health, and wealthneeds. The company also offers a broker operating system that organizes meetings, captures context, and suggests cross-sell opportunities to streamline workflow. Gyde partners with agency owners through a model that integrates technology and operational support to augment traditional brokerage functions. Its platform is built to assist licensed agents in client service and administrative tasks while facilitating comprehensive advisory interactions. | $60M | Series A | Jan 28, 2026 |  |
| Prudentia Sciences | Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development. | $20M | Series A | Jan 07, 2026 |  |
| Amae Health | Amae Health provides outpatient care that integrates psychiatric treatment, primary care, therapy, and peer support for adults living with severe mental illness. The company delivers personalized treatment plans through multidisciplinary teams comprising psychiatrists, therapists, primary care physicians, health coaches, dietitians, and peermentors. Its services cover conditions such as schizophrenia, bipolar disorder, refractory depression, trauma, and co-occurring substance-use disorders, and it emphasizes long-term engagement and whole-person wellness. Amae Health also collaborates with academic medical centers to develop clinician training programs and to use data-driven insights to refine care pathways. | $25M | Series B | Nov 06, 2025 |  |
| LightSpun | LightSpun is an AI-powered platform designed to transform and streamline healthcare administration, specifically dental insurance administration. | $13M | Series A | Sep 04, 2025 |  |
| Translucent AI | Translucent AI develops an AI-powered financial platform tailored for healthcare operators. The system automates financial reporting, consolidates data from various service lines, and provides real-time insights to support decision-making. It integrates with existing financial systems to streamline operations and reduce reliance on manualprocesses. The platform is designed to handle complex healthcare financial workflows and is built with security and compliance in mind. Translucent AI aims to enhance financial transparency and operational efficiency for healthcare organizations. | $7M | Seed | Aug 06, 2025 |  |
| Ryght AI | Synthetica Bio develops an enterprise-scale generative AI for biopharma. It empowers discovery, clinical, and commercial teams with actionable knowledge in real-time. Its platform fine-tunes LLMs for real-time data with the verified and secure customer data store. | $3M | Seed | Jun 12, 2025 |  |

10 of 26 investments shown.

## Co-investors
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 5 deals together
- [8VC](https://shizune.co/investors/profile/8vc) — VC Fund, 4 deals together
- [Array Ventures](https://shizune.co/investors/profile/array-ventures) — VC Fund, 4 deals together
- [Caffeinated Capital](https://shizune.co/investors/profile/caffeinated-capital) — VC Fund, 4 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 4 deals together
- [GreatPoint Ventures](https://shizune.co/investors/profile/greatpoint-ventures) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Virtue invest in?

Virtue invests primarily in Health Care, Artificial Intelligence and Medical startups, most often at Seed and Series A stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Virtue?

Public channels for Virtue include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Virtue?

The team at Virtue includes Sean Dolan (Founder), Emre Karatas (Partner) and Michael Ragheb (Limited Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co